The $80 million facility officially opened its doors Thursday, though patients started seeing providers there earlier this month.

Dramatic rise in gastrointestinal cancers in people under 50 - Colorectal cancer, which develops in the colon or rectum, was ...

Early-onset gastrointestinal (GI) cancers are rising at alarming rates worldwide and, in the U.S., are increasing faster than any other type of early-onset cancer, including breast cancer, according ...

SH-110, a liquid cancer treatment for glioma, earned orphan drug status from the FDA, helping patients who struggle to ...

Early-onset gastrointestinal (GI) cancers are rising at alarming rates worldwide and, in the U.S., are increasing faster than ...

Gastrointestinal cancers, which include colorectal, stomach and pancreatic cancer, are rising dramatically in younger adults.

Fewer than 1 in 5 U.S. adults aged 45-49 screened for colorectal cancer, despite guidelinesEarly-onset gastrointestinal (GI) ...

The hunt for better treatments led researchers to reimagine targeted therapies. By 2022 they had developed one that linked Herceptin to another cancer-killing drug.

Plexiform fibromyxoma is a rare primary mesenchymal tumor of the gastrointestinal tract, first reported by Takahashi in 2007 and officially recognized as a subtype of gastric mesenchymal tumor by the ...

Integrated pharmacokinetics (PK), exposure-response, safety, and efficacy data supported 6 mg/kg Q3W as the recommended Phase 2 dose (RP2D) of IBI343. This provides support for the conduct of ...

A new report reveals that gastrointestinal cancer rates are rising in young adults, with "Western diet" and lifestyle factors ...